Matches in Nanopublications for { ?s ?p "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP579576.RApiETMnD44vZ2fBZSlXVf7Nq7D2JBDLIb7r859gKIfPE130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579576.RApiETMnD44vZ2fBZSlXVf7Nq7D2JBDLIb7r859gKIfPE130_provenance.
- assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_provenance.
- NP709433.RAFLtH7aTAmZgYK-e4DXTLNn2LYyQsNRez6m_eeh_HWhQ130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709433.RAFLtH7aTAmZgYK-e4DXTLNn2LYyQsNRez6m_eeh_HWhQ130_provenance.
- NP887269.RA4CxGWehr-SXkQ3gHc0ZMatFnNBoaRrqGHWMHsyize5c130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP887269.RA4CxGWehr-SXkQ3gHc0ZMatFnNBoaRrqGHWMHsyize5c130_provenance.
- NP455828.RA_MjlrhiAFMFb4EC6AeMLDfOg2yoHyXy3LfFKCJVCbio130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455828.RA_MjlrhiAFMFb4EC6AeMLDfOg2yoHyXy3LfFKCJVCbio130_provenance.
- assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP981185.RA24UO6SVTVxxsp-YyeM2B6u2BqgAivwTwN-4yex5vK80130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981185.RA24UO6SVTVxxsp-YyeM2B6u2BqgAivwTwN-4yex5vK80130_provenance.
- NP455929.RAOSfcs9qGzscmuiuoYaa3PyVJbNN9kHQZVmp2q3GBii0130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455929.RAOSfcs9qGzscmuiuoYaa3PyVJbNN9kHQZVmp2q3GBii0130_provenance.
- NP981184.RAN_-tAiOvIRhZNKvSqAzSSoxigHq3FtkE7cNMlUnc-0w130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981184.RAN_-tAiOvIRhZNKvSqAzSSoxigHq3FtkE7cNMlUnc-0w130_provenance.
- NP981181.RAn_X_F8BeVFlTIfJcq7vQE57Vaaw7rkOKVBcQDad6gnE130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981181.RAn_X_F8BeVFlTIfJcq7vQE57Vaaw7rkOKVBcQDad6gnE130_provenance.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.